Company intelligence / Profile preview

Fisona

Cambridge, United Kingdom

Ownership: Private
Development stage: Other

Overview

Fisona is a precision medicine company focused on transforming cancer care through advanced diagnostic technologies. The company specializes in liquid biopsy solutions that analyze circulating tumor DNA and cells to provide real-time insights into tumor dynamics and treatment response. By leveraging high-sensitivity molecular profiling, Fisona aims to enable personalized therapeutic strategies and improve patient outcomes in oncology. Their platform is designed to support clinical decision-making from early detection through to monitoring for recurrence.

Therapeutic areas: Oncology
Modalities: Liquid biopsyDiagnostic test
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Fisona.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fisona.

Explore the full profile